Drug class
Antineoplastic - Taxanes
Antineoplastic taxanes are a class of plant alkaloid–derived chemotherapeutic agents that include drugs such as paclitaxel, docetaxel, and cabazitaxel. Read more about Antineoplastic - Taxanes
50 drugs in this class 41 manufacturers
Drugs in Antineoplastic - Taxanes
DOCETAXEL
DOCETAXEL
DOCETAXEL
ABRAXANE (paclitaxel protein-bound)
DOCIVYX (docetaxel)
DOCETAXEL
PACLITAXEL
PACLITAXEL PROTEIN-BOUND
Antineoplastic taxanes are a class of plant alkaloid–derived chemotherapeutic agents that include drugs such as paclitaxel, docetaxel, and cabazitaxel.
They function primarily as microtubule stabilizers, binding directly to cellular beta-tubulin to inhibit microtubule disassembly and suppress dynamic instability.
This mechanism arrests cancer cells in the mitotic (G2/M) phase of the cell cycle, ultimately triggering apoptotic cell death.
Clinically, taxanes serve as cornerstone treatments for a wide variety of solid tumors, most notably advanced breast, ovarian, non-small cell lung, prostate, and gastric cancers.
-
fda.gov
Antineoplastic taxanes are a class of plant alkaloid–derived chemotherapeutic agents that include drugs such as paclitaxel, docetaxel, and cabazitaxel
-
cancer.gov
Antineoplastic taxanes are a class of plant alkaloid–derived chemotherapeutic agents that include drugs such as paclitaxel, docetaxel, and cabazitaxel Clinically, taxanes serve as cornerstone treatments for a wide variety of solid tumors, most notably advanced breast, ovarian, non-small cell lung, prostate, and gastric cancers
-
cancer.gov
They function primarily as microtubule stabilizers, binding directly to cellular beta-tubulin to inhibit microtubule disassembly and suppress dynamic instability This mechanism arrests cancer cells in the mitotic (G2/M) phase of the cell cycle, ultimately triggering apoptotic cell death
-
cancer.gov
This mechanism arrests cancer cells in the mitotic (G2/M) phase of the cell cycle, ultimately triggering apoptotic cell death
-
fda.gov
Clinically, taxanes serve as cornerstone treatments for a wide variety of solid tumors, most notably advanced breast, ovarian, non-small cell lung, prostate, and gastric cancers
-
fda.gov
Clinically, taxanes serve as cornerstone treatments for a wide variety of solid tumors, most notably advanced breast, ovarian, non-small cell lung, prostate, and gastric cancers
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.